Discover 302 paid clinical trials in Cape Coral, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight
for
Overweight, Obesity
Location: Fort Myers FL, Tampa FL, Delray Beach FL, Birmingham AL,
Sponsor: Novo Nordisk A/S
Sex: All
Age: 18+
Code: NCT07770841
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
for
Obesity, Overweight, Obstructive Sleep Apnoea
Location: Naples FL, Bradenton FL, West Palm Beach FL,
Sponsor: Novo Nordisk A/S
Sex: All
Age: 18+
Code: NCT07571109
Phase 3, Recruiting
REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE
for
Aortic Stenosis
Location: Fort Myers FL, Tampa FL, Clearwater FL, Orlando FL,
Sponsor: Medtronic Cardiovascular
Sex: All
Age: 18 - 70+
Code: NCT06777368
Recruiting
Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Refractory Corneal Ulcers
for
Keratitis, Corneal Ulcer
Location: Fort Myers FL, Tampa FL, Columbia SC, Chattanooga TN,
Sponsor: Peschke GmbH
Sex: All
Age: 18+
Code: NCT05255016
Phase 2, Phase 3, Recruiting
A Study to Evaluate the Safety and Efficacy of NEXAGON® (Lufepirsen Ophthalmic Gel) in Subjects With PCED
for
Persistent Corneal Epithelial Defect
Location: Fort Myers FL, Bradenton FL, South Miami FL, Dothan AL,
Sponsor: Glaukos Corporation
Sex: All
Age: 2+
Code: NCT05966493
Phase 2, Recruiting
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
for
Heart Failure, Acute Heart Failure
Location: Fort Myers FL, Bradenton FL, Tamarac FL, Hialeah FL,
Sponsor: Colorado Prevention Center
Sex: All
Age: 18+
Code: NCT06008197
Phase 3, Recruiting
Study to Assess Safety and Immunogenicity of an Egg-based H5N8 Influenza Vaccine at Multiple Dose Levels Adjuvanted With Matrix-M in Healthy Participants 18 Years of Age and Above.
for
Healthy Volunteers, Influenza
Location: Fort Myers FL, Miami Lakes FL, Coral Gables FL,
Sponsor: Sanofi
Sex: All
Age: 18+
Code: NCT07779408
Phase 1, Phase 2, Recruiting
Brivekimig for the Treatment of Moderate to Severe Hidradenitis Suppurativa
for
Hidradenitis Suppurativa
Location: Fort Myers FL, Miramar FL, Miami FL, Savannah GA,
Sponsor: Sanofi
Sex: All
Age: 18+
Code: NCT07170917
Phase 2, Recruiting
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)
Location: Fort Myers FL, St. Petersburg FL, Tampa FL, Lakeland FL,
Sponsor: Adverum Biotechnologies, Inc.
Sex: All
Age: 50+
Code: NCT07482176
Phase 3, Recruiting
A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
for
Hidradenitis Suppurativa
Location: Fort Myers FL, Tampa FL, Boynton Beach FL, Hollywood FL,
Sponsor: Sanofi
Sex: All
Age: 18+
Code: NCT07225569
Phase 2, Recruiting
PEN-866 in Patients With Advanced Solid Malignancies
for
Carcinoma, Endometrial Adenocarcinoma, Neoplasms,
Location: Fort Myers FL, Saint Petersburg FL, West Palm Beach FL,
Sponsor: Tarveda Therapeutics
Sex: All
Age: 18+
Code: NCT03221400
Phase 1, Phase 2, Recruiting
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
for
Chronic Obstructive Pulmonary Disease
Location: Fort Myers FL, Tampa FL, Pembroke Pines FL,
Sponsor: Sanofi
Sex: All
Age: 40 - 70+
Code: NCT07190209
Phase 3, Recruiting
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype